SLU-PP-332 Dosage: Doses Studied, Units and Chart
What doses of SLU-PP-332 have been used in published research, how they convert to syringe units, and what is still unknown.
- Doses studied
- None found
- No dose stated in the study abstracts (PubMed search, 11 Oct 2026)
- Frequency
- Not reported
- not stated in the study abstracts
- Half-life
- Not found
- No published half-life found (PubMed search, 11 Oct 2026)
- Vial sizes sold
- 5 mg
Doses used in published studies
We list a dose only when a published study used it, with the study type and the source next to it. SLU-PP-332 is not approved, so there is no official dose.
No study dose for SLU-PP-332 was found in the abstracts we summarised (PubMed search, 11 Oct 2026).
Dose to syringe units
For a 5 mg vial mixed with 2 mL of bacteriostatic water (2.5 mg/mL), on a U-100 syringe. These are reference amounts for the math, not suggested doses.
- 0.25 mg
- 10 u
- 0.5 mg
- 20 u
- 1 mg
- 40 u
- 2 mg
- 80 u
Before anyone considers it
- SLU-PP-332 is not FDA approved for any use.
- Products sold as research chemicals are not checked by the FDA for identity, purity or dose.
- Reconstitution math (mg vs mcg, units vs mL) is the most asked question in peptide forums. Check every number twice.
- People who are pregnant, breastfeeding, or have a chronic condition need medical advice first.
The cached abstracts name no dose
The metabolic-syndrome study in obese mice gives no amount, route or frequency in its abstract.[6]
The only duration stated is 8 weeks of treatment in 21-month-old mice, with no amount.[7]
The discovery paper calls SLU-PP-332 an in vivo chemical tool, a laboratory compound rather than a medicine.[8]
Human data
The only human-derived material is pooled human liver fractions used to identify metabolites in vitro, which is not a dosing study.[9]
Drugs@FDA lists no SLU-PP-332 product, so no label supplies an amount.[10]
Common questions
How many units is 1 mg of SLU-PP-332?
It depends on the water added. A 5 mg vial with 2 mL of water gives 2.5 mg/mL, so 1 mg is 40 units on a U-100 syringe. Use the calculator for other mixes.
Is SLU-PP-332 FDA approved?
No. SLU-PP-332 is not FDA approved for any use.
What is the SLU-PP-332 dosing?
No human dosing exists. The mouse study treated 21-month-old mice for 8 weeks and its abstract gives no amount.[7]
Is there an SLU-PP-332 protocol or cycle?
No. The cited work is mouse and cell research, and Drugs@FDA lists no product.[10]
More on SLU-PP-332
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3PubMed search: "SLU-PP-332"[tiab] (10 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 4PubMed search: SLU-PP-332[tiab] OR SLU-PP-915[tiab] OR "ERR agonist"[tiab] AND exercise mimetic[tiab] (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: ("SLU-PP-332"[tiab] OR "SLU-PP-915"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 6A Synthetic ERR Agonist Alleviates Metabolic Syndrome.The Journal of pharmacology and experimental therapeutics · 2024PMID 37739806Accessed 2 Oct 2026
- 7Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney.The American journal of pathology · 2023PMID 37717940Accessed 2 Oct 2026
- 8Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.ACS chemical biology · 2023PMID 36988910Accessed 2 Oct 2026
- 9Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes.Drug testing and analysis · 2026PMID 41688415Accessed 2 Oct 2026
- 10Drugs@FDA (openFDA) search: active ingredient "SLU-PP-332"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
Found an error? Report a correction.